5-80960844-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_006909.3(RASGRF2):āc.106G>Cā(p.Ala36Pro) variant causes a missense change. The variant allele was found at a frequency of 0.0000297 in 1,613,666 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.00014 ( 0 hom., cov: 32)
Exomes š: 0.000018 ( 0 hom. )
Consequence
RASGRF2
NM_006909.3 missense
NM_006909.3 missense
Scores
5
14
Clinical Significance
Conservation
PhyloP100: 3.81
Genes affected
RASGRF2 (HGNC:9876): (Ras protein specific guanine nucleotide releasing factor 2) RAS GTPases cycle between an inactive GDP-bound state and an active GTP-bound state. This gene encodes a calcium-regulated nucleotide exchange factor activating both RAS and RAS-related protein, RAC1, through the exchange of bound GDP for GTP, thereby, coordinating the signaling of distinct mitogen-activated protein kinase pathways. [provided by RefSeq, Oct 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.07524392).
BS2
High AC in GnomAd4 at 21 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RASGRF2 | NM_006909.3 | c.106G>C | p.Ala36Pro | missense_variant | 1/27 | ENST00000265080.9 | NP_008840.1 | |
RASGRF2-AS1 | NR_105015.1 | n.64C>G | non_coding_transcript_exon_variant | 1/4 | ||||
RASGRF2 | XM_005248565.2 | c.106G>C | p.Ala36Pro | missense_variant | 1/19 | XP_005248622.1 | ||
RASGRF2 | XM_017009683.2 | c.106G>C | p.Ala36Pro | missense_variant | 1/18 | XP_016865172.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RASGRF2 | ENST00000265080.9 | c.106G>C | p.Ala36Pro | missense_variant | 1/27 | 1 | NM_006909.3 | ENSP00000265080 | P1 | |
RASGRF2-AS1 | ENST00000505694.1 | n.64C>G | non_coding_transcript_exon_variant | 1/4 | 3 | |||||
RASGRF2 | ENST00000503795.1 | c.106G>C | p.Ala36Pro | missense_variant, NMD_transcript_variant | 1/28 | 1 | ENSP00000421771 | |||
RASGRF2 | ENST00000638442.1 | c.106G>C | p.Ala36Pro | missense_variant | 1/10 | 5 | ENSP00000491428 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152200Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
22
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000282 AC: 7AN: 247954Hom.: 0 AF XY: 0.0000223 AC XY: 3AN XY: 134778
GnomAD3 exomes
AF:
AC:
7
AN:
247954
Hom.:
AF XY:
AC XY:
3
AN XY:
134778
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461348Hom.: 0 Cov.: 31 AF XY: 0.0000261 AC XY: 19AN XY: 726986
GnomAD4 exome
AF:
AC:
27
AN:
1461348
Hom.:
Cov.:
31
AF XY:
AC XY:
19
AN XY:
726986
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000138 AC: 21AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.000121 AC XY: 9AN XY: 74482
GnomAD4 genome
AF:
AC:
21
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
9
AN XY:
74482
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
2
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 17, 2021 | The c.106G>C (p.A36P) alteration is located in exon 1 (coding exon 1) of the RASGRF2 gene. This alteration results from a G to C substitution at nucleotide position 106, causing the alanine (A) at amino acid position 36 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
D;D
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;.
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.
REVEL
Benign
Sift
Benign
D;.
Sift4G
Benign
T;.
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at